Carisma Therapeutics Inc. (CARM) — Strategic Asset Allocation Index
Carisma Therapeutics Inc. (CARM) has a Strategic Asset Allocation Index of 15.9% as of June 2023. Strategic assets (PP&E of $10.64 Million plus long-term investments of $-) total $10.64 Million, measured against net assets of $66.70 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Carisma Therapeutics Inc. to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Carisma Therapeutics Inc. Strategic Asset Allocation Index (2021–2021)
This chart shows how Carisma Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 15.9%, representing strategic assets of $10.64 Million against net assets of $66.70 Million USD. See how financially flexible is Carisma Therapeutics Inc. to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Carisma Therapeutics Inc. (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Carisma Therapeutics Inc. from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Carisma Therapeutics Inc. market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.3% | $5.66 Million | $5.66 Million | $- | $171.71 Million | — |